Velan Capital Investment Management as of June 30, 2026
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 50 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Praxis Precision Medicines I Com New (PRAX) | 18.1 | $30M | 89k | 334.79 | |
| Maplight Therapeutics (MPLT) | 10.8 | $18M | 493k | 35.84 | |
| Sutro Biopharma Com Shs (STRO) | 10.4 | $17M | 512k | 33.20 | |
| Immix Biopharma (IMMX) | 6.8 | $11M | 1.1M | 10.31 | |
| Protara Therapeutics Com Stk (TARA) | 6.6 | $11M | 2.8M | 3.82 | |
| Tenax Therapeutics Com New (TENX) | 5.5 | $9.0M | 619k | 14.55 | |
| Abivax Sa Sponsored Ads (ABVX) | 5.3 | $8.7M | 66k | 133.26 | |
| Anteris Technologies Global (AVR) | 4.2 | $6.9M | 700k | 9.85 | |
| Edesa Biotech Com New (EDSA) | 4.1 | $6.7M | 828k | 8.13 | |
| Evommune Com Shs (EVMN) | 3.7 | $6.0M | 451k | 13.29 | |
| Avalo Therapeutics Com New (AVTX) | 3.7 | $6.0M | 325k | 18.48 | |
| Xencor (XNCR) | 2.5 | $4.1M | 255k | 16.10 | |
| Rezolute Com New (RZLT) | 2.4 | $3.9M | 750k | 5.20 | |
| Heron Therapeutics (HRTX) | 2.3 | $3.7M | 8.8M | 0.43 | |
| Verrica Pharmaceuticals Com Shs (VRCA) | 1.8 | $2.9M | 472k | 6.12 | |
| C4 Therapeutics Com Stk (CCCC) | 1.6 | $2.7M | 570k | 4.67 | |
| Eupraxia Pharmaceuticals (EPRX) | 1.4 | $2.3M | 352k | 6.61 | |
| Adma Biologics (ADMA) | 1.3 | $2.1M | 250k | 8.37 | |
| Rein Therapeutics Com New (RNTX) | 1.1 | $1.8M | 1.7M | 1.04 | |
| Lyell Immunopharma Com New (LYEL) | 0.9 | $1.5M | 105k | 14.05 | |
| Nasus Pharma Ord Shs (NSRX) | 0.8 | $1.3M | 359k | 3.50 | |
| Profound Med Corp Com New (PROF) | 0.7 | $1.1M | 170k | 6.65 | |
| Jasper Therapeutics Com New (JSPR) | 0.7 | $1.1M | 2.7M | 0.42 | |
| Protagonist Therapeutics (PTGX) | 0.3 | $454k | 3.7k | 122.58 | |
| Cytomx Therapeutics (CTMX) | 0.3 | $450k | 120k | 3.75 | |
| Neumora Therapeutics (NMRA) | 0.2 | $391k | 230k | 1.70 | |
| Nurix Therapeutics (NRIX) | 0.2 | $388k | 16k | 24.26 | |
| Ovid Therapeutics (OVID) | 0.2 | $350k | 130k | 2.69 | |
| Precision Biosciences Com New (DTIL) | 0.2 | $314k | 40k | 7.86 | |
| Mineralys Therapeutics (MLYS) | 0.2 | $297k | 11k | 26.98 | |
| Macrogenics (MGNX) | 0.2 | $277k | 60k | 4.62 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.1 | $244k | 26k | 9.38 | |
| Artiva Biotherapeutics (ARTV) | 0.1 | $243k | 25k | 9.70 | |
| Replimune Group (REPL) | 0.1 | $221k | 20k | 11.07 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $219k | 10k | 21.86 | |
| Immunome (IMNM) | 0.1 | $212k | 10k | 21.19 | |
| Tectonic Therapeutic (TECX) | 0.1 | $206k | 6.0k | 34.38 | |
| Rocket Pharmaceuticals (RCKT) | 0.1 | $205k | 60k | 3.42 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $195k | 20k | 9.77 | |
| An2 Therapeutics (ANTX) | 0.1 | $194k | 40k | 4.84 | |
| Miragen Therapeutics (VRDN) | 0.1 | $184k | 10k | 18.37 | |
| Scynexis | 0.1 | $163k | 40k | 4.07 | |
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.1 | $157k | 32k | 4.84 | |
| Xilio Therapeutics (XLO) | 0.1 | $137k | 14k | 9.58 | |
| Inspiremd (NSPR) | 0.1 | $104k | 148k | 0.70 | |
| Kalaris Therapeutics (KLRS) | 0.1 | $102k | 25k | 4.07 | |
| Larimar Therapeutics (LRMR) | 0.1 | $101k | 33k | 3.05 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $84k | 45k | 1.86 | |
| Context Therapeutics (CNTX) | 0.0 | $33k | 60k | 0.55 | |
| Gossamer Bio (GOSS) | 0.0 | $12k | 70k | 0.16 |